Je was op zoek naar: randomiziranimi (Sloveens - Engels)

to gre morda na račun bolnikov, randomiziranimi na npo, ki so po napredovanju dobivali panitumumab.
this may be due to patients receiving panitumumab after progression among those randomized to bsc.

a razlika v deležih in njihovi 95-odstotni iz med randomiziranimi skupinami zdravljenja temelji na normalnem približevanju.
a the difference in proportions and its 95% cis between randomised treatment groups is based on normal approximation.

klinična učinkovitost je bila dokazana v dveh s placebom nadzorovanih študijah in eni študiji z aktivnim primerjanim zdravilom s 448 bolniki, randomiziranimi za prejemanje zdravila quinsair 240 mg dvakrat na dan.
clinical efficacy was demonstrated in two placebo-controlled studies and one active-comparator study in 448 patients randomised to receive quinsair 240 mg twice daily.

duloksetin se je izkazal za statistično značilno boljšega kot placebo v petih izmed petih študij, vključno s štirimi randomiziranimi, dvojno slepimi, s placebom kontroliranimi akutnimi študijami in študijo preprečevanja relapsa pri odraslih bolnikih z generalizirano anksiozno motnjo.
duloxetine demonstrated statistically significant superiority over placebo in five out of five studies including four randomised, double-blind, placebo-controlled acute studies and a relapse prevention study in adult patients with generalised anxiety disorder.

v študiji z 880 randomiziranimi bolniki, ki se niso ustrezno odzvali na zdravljenje s 300 mg aliskirena, je uporaba kombinacije aliskirena/hidroklorotiazida 300 mg/25 mg znižala sistolični/diastolični krvni tlak za 15,8/11,0 mmhg, kar je statistično značilno več kot pri uporabi 300 mg aliskirena v monoterapiji.
in a study in 880 randomised patients not adequately responsive to aliskiren 300 mg treatment, the combination of aliskiren/hydrochlorothiazide 300 mg/25 mg produced systolic/diastolic blood pressure reductions of 15.8/11.0 mmhg, which were significantly greater than aliskiren 300 mg monotherapy.